Biotech

+

RonomA

Lilly Moran, 29 January, 2025, 0

RonomA Developing a new therapeutic approach to change the course of Alzheimer disease

+

EVIS Bioscience

Lilly Moran, 8 January, 2025, 0

EVIS Bioscience Groundbreaking EV Transfecting NanoVector with incomparable potential in therapeutical solutions

+

Neurolieve Biosciences Ltd

Lilly Moran, 8 January, 2025, 0

Neurolieve Biosciences Ltd Neurolieve Biosciences aims to improve life quality for millions with peripheral neuropathic pain.

+

Makby

Lilly Moran, 2 January, 2025, 0

Makby Making regenerative medicine the medicine of tomorrow Biotech Sales, licensing phases Spain 350.000€ Status Pending IP Type Patent Time...

+

Smart Immune

Lilly Moran, 18 December, 2024, 0

Smart Immune Revolutionizing Cell Therapy with Off-the-shelf T-cell Progenitors Biotech Development, market readiness, clinical trial France 3.000.000€ Status Approved IP...

+

Bioingenium

Lilly Moran, 12 December, 2024, 0

Bioingenium We bridge the gap between ideas and biotech products Biotech Development, market readiness, clinical trial Spain 1 250 000€...

+

SUCCIPRO

Lilly Moran, 9 December, 2024, 0

SUCCIPRO Novel succinate-modulating, first-in-class therapy for chronic inflammatory & metabolic diseases Biotech Prototyping, preclinical Spain 1.000.000€ Status Pending IP...

+

Mikrobiomik Healthcare S.L.

Lilly Moran, 28 November, 2024, 0

Mikrobiomik Healthcare S.L. Transforming healthcare with microbiome-based medicines for chronic and unmet medical needs Biotech Development, market readiness, clinical trial...

+

SPyDiag

Heidi Rohwer, 25 November, 2024, 0

SPyDiag Saving kidney transplants from the BK virus Biotech In vitro, proof of concept France 800.000€ Status Approved IP...

+

Steminov

Julie HUTIN, 22 November, 2024, 0

Steminov Our ambition is to provide patients with next-generation treatments that address immune and inflammatory diseases Biotech Prototyping, preclinical France...